GBR12909 antagonizes the ability of cocaine to elevate extracellular levels of dopamine

This publication has 32 references indexed in Scilit:

• New concepts in cocaine addiction: The dopamine depletion hypothesis
  Published by Elsevier ,2003
• The effect of intraventricular administration of the 5-HT3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: an in vivo chronocoulometric study
  Published by Elsevier ,2003
• Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study
  JAMA, 1990
• In vivo microdialysis and thermospray tandem mass spectrometry of the dopamine uptake blocker 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR-12909)
  Analytical Chemistry, 1990
• Rothman, R.B., A. Mele, A.A. Reid, H. Akunne, N. Greig, A. Thurkauf, K.C. Rice and A. Pert, Tight binding dopamine reuptake inhibitors as cocaine antagonists: A strategy for drug development (1989) FEBS Letters 257, 341-344
  FEBS Letters, 1990
• Tight binding dopamine reuptake inhibitors as cocaine antagonists
  FEBS Letters, 1989
• Differential effects of the pharmacological manipulation of serotonin systems on cocaine and amphetamine self-administration in rats
  Life Sciences, 1989
• Food reward and cocaine increase extracellular dopamine in the nucleus accumbens as measured by microdialysis
  Life Sciences, 1988
• Biochemical and Pharmacological Characterization of [³H]GBR 12935 Binding In Vitro to Rat Striatal Membranes: Labeling of the Dopamine Uptake Complex
  Journal of Neurochemistry, 1987
• Prolactin Changes after Administration of Agonist and Antagonist Dopaminergic Drugs in Puerperal Women
  Gynecologic and Obstetric Investigation, 1986